As the biggest industry-led meeting on novel vector development, the 3rd Annual Next Generation Gene Therapy Vectors Summit (June 27-29, 2023 | Boston, MA) will bring together 100+ key opinion leaders to help solve the safety, efficiency, and scalability challenges of the next generation of vectors.
Industry heavyweights such as Novartis, Spark Therapeutics, Capsida Biotherapeutics, and Dyno Therapeutics will deliver data-led seminars, workshops, and panels to aid in the progression of promising vector designs from discovery to clinical trials.
Download the brochure to see the full agenda – https://ter.li/b6qdwn
Uniting industry pioneers such as Dave Chu (Capsida Biotherapeutics), Sean Armour (Spark Therapeutics), Eric Kelsic (Dyno Therapeutics), Jing Liao (Alexion Pharmaceuticals), and others – this summit will be your ultimate roadmap to the future of the industry as it upgrades to the next generation of vectors.
Register to attend with your colleagues and get up to 20% off your tickets – https://ter.li/qlplw9